Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)

This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. Application will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions.

Funding: $400,000 total 

Duration: 3 years 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19

Full proposal due dates: 7.3.19, 28.5.19. 27.9.19